Dean Gregory
Vermogen: 206 406 $ op 30-09-2026
Vermogen: 206 406 $ op 30-09-2026
Mr. Dean A. Gregory is an Independent Director at Cerus Corp.
He is on the Board of Directors at Cerus Corp.
and Illinois Biotechnology Industry Organization.
Mr. Gregory was previously employed as a President-Global Commercial Operations by Fresenius Kabi Pharmaceuticals Holding, Inc. (United States), a Senior Vice President-Sales & Operations by Fenwal, Inc., and a VP-Business Development, Strategy & Marketing ROW by Baxter International, Inc. He received his undergraduate degree from the University of Illinois and an MBA from DePaul University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CERUS CORPORATION 0,04% | 02-06-2026 | 86.725 ( 0,04% ) | 206 406 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CERUS CORPORATION | Directeur/Bestuurslid | 01-07-2024 |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Life science industry association | Directeur/Bestuurslid | 20-01-2010 |
| Bedrijven | Functie | Einde |
|---|---|---|
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States)
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01-03-2024 |
Fenwal, Inc.
Fenwal, Inc. BiotechnologyHealth Technology Manufactures blood collection and transfusion systems | Operationeel Directeur | 18-03-2010 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01-02-2007 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Cerus Corp.
Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
DePaul University
DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fenwal, Inc.
Fenwal, Inc. BiotechnologyHealth Technology Manufactures blood collection and transfusion systems | Health Technology |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Life science industry association | Commercial Services |
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States)
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau